NEW2026 Annual Stockholders’ Meeting – December 2, 2026|Click Here for Meeting Details and Proxy MaterialsMeeting Details & Proxy Materials

IGC 8-K Presentation on its Life Sciences business

December 20, 2022

December 20, 2022

IGC 8-K Presentation on its Life Sciences business

Related Posts

IGC Pharma Adds Visionary Investigators Network as Clinical Site to Phase 2 CALMA Trial

February 23, 2026

IGC Pharma, Inc. 424B5 01-06-26

January 6, 2026

IGC Pharma, Inc 8-K 01-06-26

January 6, 2026

CEO Update

IGC Pharma Unveils PRISM™ AI Platform to Move Alzheimer’s Risk Prediction to Brain-Health Action and Commercial Deployment

October 13, 2026

IGC Pharma Completes Enrollment in Phase 2 CALMA Alzheimer’s Trial; Topline Results Expected Q4 2026

September 28, 2026